Quantitative Chemotherapeutic Profiling of Gynecologic Cancer Cell Lines Using Approved Drugs and Bioactive Compounds()

Heterogeneous response to chemotherapy is a major issue for the treatment of cancer. For most gynecologic cancers including ovarian, cervical, and placental, the list of available small molecule therapies is relatively small compared to options for other cancers. While overall cancer mortality rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorshkov, Kirill, Sima, Ni, Sun, Wei, Lu, Billy, Huang, Wei, Travers, Jameson, Klumpp-Thomas, Carleen, Michael, Samuel G., Xu, Tuan, Huang, Ruili, Lee, Emily M., Cheng, Xiaodong, Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302136/
https://www.ncbi.nlm.nih.gov/pubmed/30576957
http://dx.doi.org/10.1016/j.tranon.2018.11.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302136/
https://www.ncbi.nlm.nih.gov/pubmed/30576957
http://dx.doi.org/10.1016/j.tranon.2018.11.016

Ejemplares similares